Established 2020
Documented successes: Over five years reviewed more than 500 applications, selected more than 30 projects, engaged over 200 Stanford innovators, completed 12 clinical pilots and translated 13 projects into companies, licenses or partnerships (Stanford Medicine magazine); AVATAR, a projection device used during pediatric radiation therapy, helped 78% of children avoid anesthesia and has been deployed in more than 12 countries (Stanford Medicine magazine); A Catalyst-backed radiopharmaceutical team secured a $35 million ARPA-H contract (Stanford Medicine magazine); Provides capital of up to $1 million per project (Stanford Medicine Catalyst FAQ)